Literature DB >> 11773261

Treated natural history of superficial bladder cancer.

S Ozono1, S Hinotsu, S Tabata, K Takashima, K Fujimoto, E Okajima, Y Hirao, Y Ohashi, H Akaza, S Fukushima.   

Abstract

BACKGROUND: The present study was conducted to examine the natural history of superficial bladder cancer.
METHODS: One hundred and forty-four patients with superficial bladder cancer who had been treated with transurethral resection of bladder tumor (TURBt) alone were analyzed.
RESULTS: The non-recurrence rate was 64.8% at 36 months and 61.2% at 60 months after TURBt. When the non-recurrence rate after TURBt was analyzed by background variables, the rate differed significantly between the solitary tumor group and the multiple tumor group. The tumor recurrence hazard curves for the entire population had one high peak before 500 days and another slight peak around 1500 days after TURBt.
CONCLUSIONS: These results will provide basic information useful when evaluating new regimens of intravesical instillation therapy for prophylaxis of superficial bladder cancer after our complete TURBt in the Nara Uro-Oncology Research Group.

Entities:  

Mesh:

Year:  2001        PMID: 11773261     DOI: 10.1093/jjco/hye114

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

Review 1.  Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer.

Authors:  Alon Z Weizer; Christopher Tallman; Jeffrey S Montgomery
Journal:  World J Urol       Date:  2010-11-28       Impact factor: 4.226

2.  Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results.

Authors:  Jean de la Rosette; Alexey Martov; Rodolfo Hurle; Gabriel Favre; Charalampos Mamoulakis; Manuel Castanheira de Oliveira; Arnulf Stenzl; Estefania Linares-Espinós; Carlos R Trelles Guzmán; Stavros Gravas; Thomas Knoll; Mustafa Yucel Boz; Thomas Herrmann; Pilar Laguna
Journal:  World J Urol       Date:  2021-11-06       Impact factor: 4.226

3.  5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.

Authors:  Shigehiro Tsujimoto; Kiyohide Fujimoto; Eijiro Okajima; Seiichiro Ozono; Eigoro Okajima; Yoshihiko Hirao
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

Review 4.  Active surveillance for nonmuscle invasive bladder cancer.

Authors:  Makito Miyake; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  Investig Clin Urol       Date:  2016-05-27

5.  Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.

Authors:  Makito Miyake; Nobutaka Nishimura; Yasushi Nakai; Tomomi Fujii; Takuya Owari; Shunta Hori; Yosuke Morizawa; Daisuke Gotoh; Satoshi Anai; Kazumasa Torimoto; Nobumichi Tanaka; Yoshihiko Hirao; Kiyohide Fujimoto
Journal:  Diagnostics (Basel)       Date:  2021-01-28

6.  Expression and role of GPR87 in urothelial carcinoma of the bladder.

Authors:  Homare Okazoe; Xia Zhang; Dage Liu; Shinsuke Shibuya; Nobufumi Ueda; Mikio Sugimoto; Yoshiyuki Kakehi
Journal:  Int J Mol Sci       Date:  2013-06-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.